#Cerebral blood flow

Cerebral blood flow (CBF) refers to the delivery of blood to brain tissue to meet its high metabolic demands. Despite fluctuations in systemic physiology, the brain maintains a relatively constant blood flow through tightly regulated mechanisms.

CBF can be described using a pressure–flow relationship:

• CBF = CPP / CVR
  • CPP = cerebral perfusion pressure
  • CVR = cerebral vascular resistance
• CPP = MAP − (ICP or cerebral venous pressure)*
  • *whichever is highest
  • MAP = mean arterial pressure
  • ICP = intracranial pressure

This reflects a modified form of Ohm’s law, where flow is determined by the pressure gradient divided by resistance.

The brain receives dual blood supply via:

• Internal carotid arteries (70%)
• Vertebral arteries (30%)

#List the normal parameters for cerebral blood flow

Normal values for CBF highlight both its magnitude and physiological importance:

• 50 mL/min per 100 g of brain tissue
• 15% of cardiac output
• Cerebral metabolic rate of oxygen (CMRO₂): 3-3.5 mL/100g/min

Additional key physiological ranges:

• Autoregulation range:

  • MAP ~50–150 mmHg
  • (corresponding CPP ~60–160 mmHg)

• CO₂ responsiveness:

  • Linear relationship between PaCO₂ ~20–60 mmHg

• O₂ responsiveness:

  • Significant vasodilation when PaO₂ <50 mmHg

Regional variation exists:

• Grey matter has higher metabolic demand → higher blood flow than white matter

#Describe the physiological factors that influence cerebral blood flow

CBF is determined by the interaction between vascular resistance, metabolic demand, and external physiological factors.

---

#1. Vascular resistance (Hagen–Poiseuille relationship)

Cerebral vascular resistance (CVR) is primarily determined by vessel radius:

• R ∝ (viscosity × length) / radius⁴

Key implications:

• Small changes in vessel radius → large changes in flow (most important factor)
• ↑ Viscosity (e.g. high haematocrit, hyperproteinaemia) → ↓ CBF
• Vessel length is essentially constant

---

#2. Autoregulation

The brain maintains relatively constant CBF across a range of perfusion pressures via intrinsic vascular responses.

#Carbon dioxide and pH

• One of the most important regulators
• Relationship is sigmoidal, approximately linear between PaCO₂ 20–60 mmHg
• ↓ pH (↑ H⁺) → vasodilation → ↑ CBF (can double flow)

Mechanisms:

• ↑ H⁺ → ↑ nitric oxide synthase activity → ↑ cGMP → Ca2+/K+ efflux → vascular smooth muscle hyperpolarisation and relaxation
• CO₂ diffuses into CSF → forms carbonic acid → dissociates → ↑ H⁺
• Effect attenuates over time via bicarbonate buffering, for example in chronic hypercapnic patients ('CO2 retainers')

Other contributors:

• Lactate and pyruvate also promote vasodilation

#Oxygen (PaO₂)

• Minimal effect until PaO₂ <50 mmHg
• Below this threshold → marked vasodilation
• Mechanism likely multifactorial (metabolic, nitric oxide, direct vascular effects)

#Metabolic coupling (CMRO₂)

Regional blood flow is linked to metabolic demand.

• Increased neuronal activity → ↑ intracellular Ca²⁺ in astrocytes
• Astrocytes release vasodilators:
  • Adenosine
  • Nitric oxide
  • Potassium

There is a linear relationship between CBF and cerebral metabolic rate.

• ↓ CMRO₂ → ↓ CBF

Modifiers:

• Temperature: ↓ CMRO₂ by ~7% per 1°C decrease in body temperature
• Drugs: e.g. many sedative agents reduce CMRO₂ and CBF

#Myogenic autoregulation

• Vascular smooth muscle constricts in response to increased transmural pressure

  • Likely mediated by stretch-induced calcium influx → vasoconstriction
  • This means that cerebral blood flow does not normally change with blood pressure
  • This effect is maintained within a MAP range of ~50–150 mmHg, (corresponding CPP ~60–160 mmHg)

• This means:

  • If MAP exceeds 150 mmHg, cerebral blood flow will increase
  • If MAP falls below 50 mmHg, cerebral blood flow will decrease
  • When MAP varies between 50-150 mmHg, there is no change in CBF

Notably, chronic hypertension causes a rightward shift of the autoregulation curve. In other words, the MAP autoregulation range is higher in chronically hypertensive patients.

#Endothelial factors

• Nitric oxide (NO): vasodilation (e.g. in response to shear stress)
• Endothelin: potent vasoconstrictor

---

#3. External and systemic factors

#Intracranial pressure (ICP)

Changes to ICP generally do not affect CBF due to the action of autoregulation mechanisms.

However, when autoregulation is overwhelmed, flow becomes pressure-dependent.

• ↑ ICP → ↓ CPP → ↓ CBF

Causes: intracranial haemorrhage, obstructive hydrocephalus, tumour, abscess

#Venous pressure and outflow

Impaired venous drainage increases venous pressure and decreases the pressure gradient for flow. This could be caused by:

• Venous obstruction (e.g. thrombus, tumour)
• ↑ intrathoracic pressure (e.g. positive pressure ventilation)
• Right heart dysfunction
• Fluid overload
• Posture and gravity

#Outline the effects of propofol and ketamine on cerebral blood flow (CBF), cerebral metabolic requirement for oxygen (CMRO₂), and cerebral venous oxygen saturation

Parameter	Propofol	Ketamine
CBF	↓ (dose-dependent)	↑ (dose-dependent)
CMRO₂	↓ (dose-dependent)	↑ (mild increase)
Cerebral venous O₂ saturation	↔	↔
Autoregulation / CO₂ response	Preserved	Likely preserved

#Explanation

• Propofol reduces neuronal activity, leading to a parallel decrease in CBF and CMRO₂ (flow–metabolism coupling preserved), so cerebral venous O₂ saturation remains largely unchanged.

• Ketamine increases neuronal activity via disinhibition (NMDA antagonism on inhibitory interneurons), causing ↑ CMRO₂ and a greater ↑ in CBF; the balance between supply and demand is maintained, so venous O₂ saturation changes little.

• In both agents, coupling between oxygen delivery and consumption is preserved, explaining the minimal net effect on cerebral venous oxygen saturation.

#Summary

CBF is tightly regulated through a combination of:

• Pressure–flow relationships (CPP, CVR)
• Vascular tone
• Chemical control (CO₂, pH, O₂)
• Metabolic demand (CMRO₂)
• Mechanical and systemic influences (ICP, venous pressure, MAP)

These mechanisms ensure stable cerebral perfusion while allowing rapid regional adaptation to metabolic needs.